Product Information
CAPLYTA 10.5 MG CAPSULE is a brand product labeled by Intra-Cellular Therapies, Inc, priced at $57.2923 per EA under NDC 72060011040. Its NADAC has been published 175 times since Feb 22, 2023.
Strength
10.5 mg/1
Manufacturer
Intra-Cellular Therapies, IncNDC
72060011040
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LUMATEPERONEApproval Type
New Drug (NDA)
FDA Application
NDA209500On Market Since
8/9/2022
Pharmacological Classes
Price Statistics
The NADAC for CAPLYTA 10.5 MG CAPSULE has been published 175 times since Feb 22, 2023, and over the history we have for it it has risen 14.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.2923 per EA |
|---|---|
| All-time high | $57.3988 (May 13, 2026) |
| All-time low | $50.0661 (Feb 22, 2023) |
| 52-week high | $57.3988 |
| 52-week low | $54.6268 |
| Median price | $53.2374 |
| Average price | $53.3960 |
| Largest weekly change | +5.9% (Jan 3, 2024) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lumateperone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CAPLYTA 10.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CAPLYTA 10.5 MG CAPSULE, manufactured by Intra-Cellular Therapies, Inc, is $57.2923 per EA (NDC 72060011040), effective Jun 24, 2026.
How has the price of CAPLYTA 10.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CAPLYTA 10.5 MG CAPSULE has risen 14.4%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for CAPLYTA 10.5 MG CAPSULE?
Since Feb 22, 2023, the NADAC for CAPLYTA 10.5 MG CAPSULE has ranged from a low of $50.0661 (Feb 22, 2023) to a high of $57.3988 (May 13, 2026), with a median of $53.2374 per EA.
Are there cheaper alternatives to CAPLYTA 10.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CAPLYTA 10.5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures CAPLYTA 10.5 MG CAPSULE?
CAPLYTA 10.5 MG CAPSULE (NDC 72060011040) is labeled by Intra-Cellular Therapies, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification